Prof. Dr. Markus Weber

Prof. Dr. Weber is Professor of Neurology at the University of Basel and serves as chief of the Neuromuscular Diseases Unit/ ALS Clinic at the Kantonsspital St. Gallen in Switzerland. Following completion of his residency at various academic hospitals in Germany and clinical fellowship in neuromuscular disorders at the University of British Columbia in Vancouver, Canada (1997-2000) he founded the Neuromuscular Diseases Center/ALS Clinic in St. Gallen, Switzerland.

His main research interests cover outcome measures, clinical neurophysiology, trial designs and cannabinoid research. His work was crucial in developing a motor unit estimation technique called MUNIX as a biomarker for ALS trials. In collaboration with the ETH Zürich, the first cannabinoid type 2 radioligand has been developed, which is now available for clinical use.